Douglas Lind
Presidente en TMune Therapeutics, Inc. .
Perfil
Dr. Douglas D.
Lind, MD, is a Managing Director at Biomark Capital Management Co. LLC and a Co-President & Director at TMune Therapeutics, Inc. He is on the Board of Directors at TMune Therapeutics, Inc., HyperMed Imaging, Inc. and Lentigen Technology, Inc.
Dr. Lind was previously employed as an Independent Director by Enveric Biosciences, Inc., a Managing Director by Burrill & Co. LLC, an Analyst by Morgan Stanley & Co., Inc., a Research Analyst by PaineWebber, Inc., and a Managing Director by GBP Capital.
He also served on the board at Flexible Stenting Solutions, Inc., MabVax Therapeutics, Inc., Opus Bio, Inc., Spectral Image, Inc., Strand Life Sciences Pvt Ltd.
and Viragen, Inc.
He received his graduate degree from the University of Iowa.
Cargos activos de Douglas Lind
| Empresas | Cargo | Inicio |
|---|---|---|
TMune Therapeutics, Inc.
 TMune Therapeutics, Inc. BiotechnologyHealth Technology TMune Therapeutics, Inc. provides cancer treatment research and technology development services. It focuses on the development of T-cell therapies for the treatment of cancer and infectious diseases. The firm's proprietary cell activation technology is used and administered in patients, who are undergoing treatment for leukemia, lymphoma, and HIV. The company was founded by Louis P. Berneman in 2008 and is headquartered in Greenwich, CT. | Presidente | - |
HyperMed Imaging, Inc.
 HyperMed Imaging, Inc. Medical SpecialtiesHealth Technology HyperMed Imaging, Inc. engages in the manufacture of medical imaging device. It offers HyperView, is a handheld, battery operated, portable diagnostic imaging device that is use to determine oxygenation levels in superficial tissues for patients with potential circulatory compromise. The company was founded in 2006 and is headquartered in Memphis, TN. | Director/Miembro de la Junta | - |
Biomark Capital Management Co. LLC
 Biomark Capital Management Co. LLC Investment ManagersFinance Biomark Capital Management Co. LLC (Biomark Capital) is a private equity and venture capital firm founded in 2011 by David S. Wetherell. The firm is headquartered in Greenwich, Connecticut. | Inversor de Capital Privado | 01/11/2013 |
Lentigen Technology, Inc.
 Lentigen Technology, Inc. BiotechnologyHealth Technology Lentigen Technology, Inc. engages in providing biotechnology services. The company was founded in 2014 and is headquartered in Gaithersburg, MD. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Douglas Lind.
| Empresas | Cargo | Fin |
|---|---|---|
Burrill LLC
 Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Inversor de Capital Privado | 31/10/2013 |
Viragen, Inc.
 Viragen, Inc. BiotechnologyHealth Technology Viragen, Inc. is a biotechnology company specializing in the research, development and commercialization of natural and recombinant protein-based drugs designed to treat a broad range of viral and malignant diseases. These protein-based drugs include natural human alpha interferon and monoclonal antibodies. Viragen's strategy also includes the development of Avian Transgenic Technology as a biomanufacturing platform for the large-scale, cost-effective production of therapeutic proteins. The firm is located in Plantation, FL. | Director/Miembro de la Junta | 01/02/2005 |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Analyst-Equity | 24/01/2002 |
| PaineWebber, Inc. | Corporate Officer/Principal | 31/12/1996 |
| ENVERIC BIOSCIENCES, INC. | Director/Miembro de la Junta | - |
Formación de Douglas Lind.
| University of Iowa | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ENVERIC BIOSCIENCES, INC. | Health Technology |
| Empresas privadas | 14 |
|---|---|
Viragen, Inc.
Viragen, Inc. BiotechnologyHealth Technology Viragen, Inc. is a biotechnology company specializing in the research, development and commercialization of natural and recombinant protein-based drugs designed to treat a broad range of viral and malignant diseases. These protein-based drugs include natural human alpha interferon and monoclonal antibodies. Viragen's strategy also includes the development of Avian Transgenic Technology as a biomanufacturing platform for the large-scale, cost-effective production of therapeutic proteins. The firm is located in Plantation, FL. | Health Technology |
MabVax Therapeutics, Inc.
 MabVax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology MabVax Therapeutics, Inc. developed and commercialized immunotherapeutics for the treatment of cancer. The company was founded in 2006 and is headquartered in San Diego, CA. | Health Technology |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Finance |
Burrill LLC
Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Finance |
| PaineWebber, Inc. | Finance |
Opus Bio, Inc.
 Opus Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Opus Bio, Inc. develops and manufactures lentiviral gene delivery technologies. Its Lentiviral vectors (LV), technology platform is used for delivery of genetic sequence information into cells to reprogram function and to treat epithelial cancers. The company was founded by Boro Dropulic in 2004 and is headquartered in Baltimore, MD. | Commercial Services |
Strand Life Sciences Pvt Ltd.
 Strand Life Sciences Pvt Ltd. Packaged SoftwareTechnology Services Strand Life Sciences Pvt Ltd. develops software for drug research. It offers developing and marketing of various diagnostics tests for cancer and hereditary diseases. The firm also offers liquid biopsy test, somatic test, hereditary cancer test and inherited diseases test. The company was founded by Vijay Chandru, Ramesh Hariharan, Srinivasan Seshadri, Vinay Vishwanathan and Swaminathan Manohar in 2000 and is headquartered in Bangalore, India. | Technology Services |
GBP Capital
 GBP Capital Investment ManagersFinance Founded in 2005, GBP Capital is a venture capital firm located in Greenwich, Connecticut. | Finance |
Spectral Image, Inc.
 Spectral Image, Inc. Medical SpecialtiesHealth Technology Spectral Image, Inc. developed imaging technology for biomedical use. The company was headquartered in Tampa, FL. | Health Technology |
Flexible Stenting Solutions, Inc.
 Flexible Stenting Solutions, Inc. Medical/Nursing ServicesHealth Services Flexible Stenting Solutions, Inc. manufactures and distributes medical devices. It develops third-generation flexible peripheral arterial, venous, neurovascular and biliary stents. The company was founded by Janet W. Burpee in 2006 and is headquartered in Eatontown, NJ. | Health Services |
TMune Therapeutics, Inc.
TMune Therapeutics, Inc. BiotechnologyHealth Technology TMune Therapeutics, Inc. provides cancer treatment research and technology development services. It focuses on the development of T-cell therapies for the treatment of cancer and infectious diseases. The firm's proprietary cell activation technology is used and administered in patients, who are undergoing treatment for leukemia, lymphoma, and HIV. The company was founded by Louis P. Berneman in 2008 and is headquartered in Greenwich, CT. | Health Technology |
HyperMed Imaging, Inc.
HyperMed Imaging, Inc. Medical SpecialtiesHealth Technology HyperMed Imaging, Inc. engages in the manufacture of medical imaging device. It offers HyperView, is a handheld, battery operated, portable diagnostic imaging device that is use to determine oxygenation levels in superficial tissues for patients with potential circulatory compromise. The company was founded in 2006 and is headquartered in Memphis, TN. | Health Technology |
Biomark Capital Management Co. LLC
Biomark Capital Management Co. LLC Investment ManagersFinance Biomark Capital Management Co. LLC (Biomark Capital) is a private equity and venture capital firm founded in 2011 by David S. Wetherell. The firm is headquartered in Greenwich, Connecticut. | Finance |
Lentigen Technology, Inc.
Lentigen Technology, Inc. BiotechnologyHealth Technology Lentigen Technology, Inc. engages in providing biotechnology services. The company was founded in 2014 and is headquartered in Gaithersburg, MD. | Health Technology |
- Bolsa de valores
- Insiders
- Douglas Lind
